Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer

Gastric cancer is a common cancer in the world with higher incidence rates. Micro RNAs (miRNAs) are known to control biological processes and are also involved in the initiation and progression of numerous cancers. The aim of this study was to identify small molecule inhibitors using bioinformatics methods for over-expressed miRNAs that are known to play a major role in the genesis of gastric cancer. Our study included three datasets from Gene expression omnibus (GEO) database and we used bioinformatics tool to identify differentially expressed miRNAs in all the three datasets. Gene ontology and pathway enrichment analysis of the experimentally validated miRNA target genes and their linkage to oncogenesis were analyzed. Target genes thus identified were found to be linked with the major pathways of cancer. We were interested in identifying small molecules which are specific to over-expressed miRNAs which can arrest oncogenesis. Thus, the computer aided high throughput virtual screening was carried out to identify potent small molecules for over expressed miRNAs in gastric cancer using Glide. Based on docking score top five ligands specific for each miRNAs were identified.

[1]  Ankita Mehta,et al.  SMMRNA: a database of small molecule modulators of RNA , 2013, Nucleic Acids Res..

[2]  Lin Jiang,et al.  Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer. , 2014, Gene.

[3]  George P Cobb,et al.  microRNAs as oncogenes and tumor suppressors. , 2007, Developmental biology.

[4]  M. Ebert,et al.  LGR4 and LGR6 are differentially expressed and of putative tumor biological significance in gastric carcinoma , 2012, Virchows Archiv.

[5]  Hualiang Jiang,et al.  Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. , 2014, Carcinogenesis.

[6]  P. Gao,et al.  The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. , 2014, International journal of clinical and experimental pathology.

[7]  Y. Nakamura,et al.  Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells. , 2000, Archives of pathology & laboratory medicine.

[8]  Shu-Hui Lin,et al.  Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma , 2013, Medical Oncology.

[9]  Ying Chen,et al.  Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer , 2010, BMC Cancer.

[10]  Yanyan Zhou,et al.  MiR-26a Enhances the Sensitivity of Gastric Cancer Cells to Cisplatin by Targeting NRAS and E2F2 , 2015, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[11]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[12]  Isabella Castiglioni,et al.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer , 2015, Theranostics.

[13]  G. Calin,et al.  Targeting MicroRNAs With Small Molecules: From Dream to Reality , 2010, Clinical pharmacology and therapeutics.

[14]  Tao Qian,et al.  Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer , 2012, World Journal of Surgical Oncology.

[15]  E. Hahn,et al.  Expression of Survivin and Caspase-3 in Gastric Cancer , 2003, Digestive Diseases and Sciences.

[16]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[17]  F. Major,et al.  The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data , 2008, Nature.

[18]  Keehyoung Joo,et al.  Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: Four approaches that performed well in CASP8 , 2009, Proteins.

[19]  D. Dai,et al.  Genome-wide analysis of histone modifications by ChIP-chip to identify silenced genes in gastric cancer. , 2015, Oncology reports.

[20]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[21]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[22]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[23]  P. Yin,et al.  miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation , 2016, Tumor Biology.

[24]  Min Han,et al.  [Expression and clinical significance of Sema4C in esophageal cancer, gastric cancer and rectal cancer]. , 2012, Zhonghua yi xue za zhi.

[25]  T. Ha.  MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease , 2011, Immune network.

[26]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[27]  Wei Zhang,et al.  Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. , 2012, Cancer letters.

[28]  Tongshan Wang,et al.  MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation , 2012, Cancer biology & therapy.

[29]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[30]  Sung-Chou Li,et al.  MicroRNA dysregulation in gastric cancer. , 2012, Current pharmaceutical design.

[31]  Jianmin Si,et al.  MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 , 2010, Cell Research.

[32]  S. Choi,et al.  Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation , 2017, Gastric Cancer.

[33]  Li-hui Wang,et al.  Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. , 2008, Histology and histopathology.

[34]  C. Deltas,et al.  microRNAs: a newly described class of encoded molecules that play a role in health and disease. , 2010, Hippokratia.

[35]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[36]  Yan Wu,et al.  AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells , 2015, Molecular and Cellular Biochemistry.

[37]  B. Shen,et al.  MicroRNA‐339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1 , 2015, FEBS letters.

[38]  J. Pyo,et al.  Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression , 2015, British Journal of Cancer.

[39]  Lei Han,et al.  AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. , 2013, Cancer research.

[40]  N. Yoo,et al.  Genetic and expressional alterations of CHD genes in gastric and colorectal cancers , 2011, Histopathology.

[41]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[42]  L. Xue,et al.  Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma. , 2016, Human pathology.

[43]  Yueli Liu,et al.  Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3. , 2014, Molecular medicine reports.

[44]  W. Kang,et al.  MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4. , 2015, Biochemical and biophysical research communications.

[45]  Qihong Huang,et al.  Small-molecule inhibitors of microrna miR-21 function. , 2008, Angewandte Chemie.

[46]  Xiaowei Wang,et al.  miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..

[47]  Minhu Chen,et al.  Expression of CDC25 Phosphatases in Human Gastric Cancer , 2008, Digestive Diseases and Sciences.

[48]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[49]  Hongwei Zhang,et al.  miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.

[50]  Ram I Mahato,et al.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Jian-Hong Wu,et al.  Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[52]  S. Neubacher,et al.  Short and Efficient Synthesis of Alkyne‐Modified Amino Glycoside Building Blocks , 2009 .

[53]  Yang Peng,et al.  microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition , 2014, Oncology letters.

[54]  C. Meijer,et al.  Focal aberrations indicate EYA2 and hsa‐miR‐375 as oncogene and tumor suppressor in cervical carcinogenesis , 2013, Genes, chromosomes & cancer.

[55]  C. Arenz,et al.  A homogenous assay for micro RNA maturation. , 2006, Angewandte Chemie.

[56]  Zong-fang Li,et al.  miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells , 2015, Oncotarget.

[57]  Lei Zhang,et al.  Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[58]  Chi Zhang,et al.  Iranian Journal of Basic Medical Sciences Mir‐493 Blockinsuppresses Blockinthe Blockinproliferation Blockinand Blockininvasion Blockinof Blockingastric Cancer Blockincells Blockinby Blockintargeting Blockinrhoc , 2022 .

[59]  P. Assumpção,et al.  Clinical implication of 14-3-3 epsilon expression in gastric cancer. , 2012, World journal of gastroenterology.

[60]  Xianghuo He,et al.  MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers , 2012, Oncogene.

[61]  Hiroyuki Yamamoto,et al.  Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. , 2008, World journal of gastroenterology.

[62]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[63]  Ling Xu,et al.  Increased Expression of Cellular Repressor of E1A-Stimulated Gene (CREG) in Gastric Cancer Patients: A Mechanism of Proliferation and Metastasis in Cancer , 2011, Digestive Diseases and Sciences.

[64]  Jessica L. Childs-Disney,et al.  Small Molecule Targeting of a MicroRNA Associated with Hepatocellular Carcinoma. , 2016, ACS chemical biology.

[65]  S. Natsugoe,et al.  Prognostic value of CCR7 expression in gastric cancer. , 2007, Hepato-gastroenterology.

[66]  Hua-Chuan Zheng,et al.  COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas. , 2013, Human pathology.

[67]  Guoxin Zhang,et al.  MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression , 2015, Digestive Diseases and Sciences.

[68]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[69]  Min Yan,et al.  MiRNA-199a-3p in Plasma as a Potential Diagnostic Biomarker for Gastric Cancer , 2013, Annals of Surgical Oncology.

[70]  R. Xing,et al.  MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. , 2015, American journal of cancer research.

[71]  M. Nakao,et al.  HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. , 2009, The American journal of pathology.

[72]  M. Ho,et al.  Interrogation of microRNAs involved in gastric cancer using 5p-arm and 3p-arm annotated microRNAs. , 2015, Anticancer research.

[73]  S. Cai,et al.  Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients , 2015, Journal of Cancer Research and Clinical Oncology.

[74]  Douglas D Young,et al.  Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. , 2010, Journal of the American Chemical Society.

[75]  K. Naka,et al.  Expression of the E2F family in human gastrointestinal carcinomas , 1999, International journal of cancer.

[76]  Hiroki Kuniyasu,et al.  Accumulation of DNA methylation is associated with tumor stage in gastric cancer , 2006, Cancer.

[77]  T. Hu,et al.  The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer , 2013, Tumor Biology.

[78]  Jun Liu,et al.  MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer , 2015, Cellular Physiology and Biochemistry.

[79]  Steven Y. Cheng,et al.  MicroRNA-206 suppresses gastric cancer cell growth and metastasis , 2014, Cell & Bioscience.

[80]  A. Schetter,et al.  MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival , 2009, Clinical Cancer Research.

[81]  Y. Mitani,et al.  Gene Expression Profile of Gastric Carcinoma , 2004, Cancer Research.

[82]  Zheng Li,et al.  ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway , 2016, Tumor Biology.

[83]  C. Arenz,et al.  A fluorescence probe for assaying micro RNA maturation. , 2008, Bioorganic & medicinal chemistry.

[84]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[85]  Xiao-li Zhang,et al.  Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. , 2005, Carcinogenesis.

[86]  Yih-Leong Chang,et al.  MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 , 2013, Nature Communications.

[87]  Zhi-hong Ma,et al.  Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma. , 2015, International journal of clinical and experimental pathology.

[88]  J. Cen,et al.  MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. , 2012, Oncology research.

[89]  Hua-Chuan Zheng,et al.  Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. , 2003, World journal of gastroenterology.

[90]  Souvik Maiti,et al.  The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. , 2012, Angewandte Chemie.

[91]  Hsien-Da Huang,et al.  A systematic review of microRNA expression profiling studies in human gastric cancer , 2014, Cancer medicine.